Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

1.17
Delayed Data
As of 9:58am ET
 -0.02 / -1.68%
Today’s Change
0.83
Today|||52-Week Range
5.75
-44.29%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close1.19
Today’s open1.19
Day’s range1.17 - 1.19
Volume13,310
Average volume (3 months)743,857
Market cap$32.8M
Dividend yield--
Data as of 9:58am ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+23.97%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VKTXViking Therapeutics ...+0.02+1.62%
MRNSMarinus Pharmaceutic...0.000.00%
SVRASavara Inc+9.45+7,212.98%
PRPHProPhase Labs Inc0.000.00%
Data as of 9:58am ET, 04/28/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts